Overview

Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This prospective, randomized, controlled study aims to investigate the effects of atorvastatin treatment in hemodialysis patients concerning progression of coronary artery calcification, progression of carotid artery intima-media thickness, endothelial function, and inflammation.
Phase:
Phase 3
Details
Lead Sponsor:
Ercan OK
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium